Ares Trading S.A.
Known title: 10% OwnerCIK: 0001720283
Associated companies
Transaction History
| PGEN | ▼ Sell | Open Market | 79,896 | $367K | 10/13/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 63,900 | $299K | 10/12/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 68,900 | $322K | 10/11/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 47,304 | $222K | 10/8/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 65,300 | $316K | 10/7/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 47,800 | $233K | 10/6/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 65,654 | $331K | 10/5/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 9,700 | $49K | 10/4/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 3,000 | $15K | 10/1/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 100 | $510 | 9/30/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 4,584 | $29K | 9/10/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 88,221 | $556K | 9/9/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 2,400 | $15K | 9/8/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 29,065 | $187K | 9/3/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 139,415 | $869K | 9/2/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 254,932 | $1.6M | 9/1/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 20,000 | $119K | 8/31/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 30,000 | $179K | 8/30/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 91,600 | $548K | 8/27/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 111,229 | $661K | 8/26/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 45,200 | $262K | 8/25/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 33,407 | $196K | 8/24/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 6,313 | $39K | 8/16/2021 | View on chart |
| PGEN | ▼ Sell | Open Market | 52,031 | $322K | 8/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Precigen mentioned in Zacks analyst blog
Precigen was highlighted in a Zacks analyst blog alongside other companies. The stock has risen more than 50% over the last three months, moving within its 52-week range of $2.99 to $8.98. Analysts currently have an average price target of $13.65 for the shares.
Precigen mentioned in Zacks analyst blog. Precigen was highlighted in a Zacks analyst blog alongside other companies. The stock has risen more than 50% over the last three months, moving within its 52-week range of $2.99 to $8.98. Analysts currently have an average price target of $13.65 for the shares.